| RESEARCH ARTICLE |
|
| Year : 2009 | Volume
: 30
| Issue : 2 | Page : 164-170 |
|
|
A clinical study on the management of Amavata (Rheumatoid arthritis) with Simhanada guggulu and Alambushadi churna tablet
Saroj Kumar Debnath1, Sudhaben N Vyas2
1 Ph.D. (Ayu.), Dept. of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
2 Professor & H.O.D., Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar, India
Correspondence Address:
Saroj Kumar Debnath
Ph.D. (Ayu.), Dept. of Kayachikitsa, Institute for Post Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar
India
 Source of Support: None, Conflict of Interest: None  | Check |
|
|
|
In this clinical study, 90 patients of Amavata (Rheumatoid arthritis) were registered from the O.P.D. & I.P.D., Deptt. of the Kayachikitsa, I.P.G.T. & R.A., G.A.U., Jamnagar. In Group-A, 40 patients completed the treatment out of 44 patients and 4 patients left the treatment before completion of the course and the treatment schedule was :- Alambushadi churna 4 tablets orally thrice daily with warm milk for 45 days (Each tablet containing 500mg Alambushadi churna) along with 1gm Simhanada guggulu orally thrice daily with warm water for 45 days and Shatapushpadi lepa applied locally over affected joints with warm water for 45 days. In Group-B, 40 patients completed the treatment out of 46 patients and 4 patients left the treatment before completion of the course. The treatment schedule was : Simhanada guggulu & Shatapushpadi lepa both given in same dose & duration as in Group-A. In Group-A maximum patients i.e. 65 % showed major improvement, while in Group-B maximum patients i.e. 50 % showed minor improvement. No side effects of the research drugs were observed during the clinical trial. Group-A therapy is more effective than Group-B therapy in this clinical study. |
|
|
|
| [PDF]* |
|
 |
|
